Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen

Bone Marrow Transplantation

Volumn 26, Issue 12, 2000, Pages 1351-1354

  Ungkanont, A ^a   Mongkonsritrakoon, W ^b   Jootar, S ^a   Srichaikul, T ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b PRAMONGKUTKLAO HOSPITAL   (Thailand)

^c Vichaiyut Hospital   (Thailand)

Author keywords

Allogeneic transplantation; Burkitt's lymphoma; GVHD; Mycophenolate; Non myeloablative; Tacrolimus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BLEOMYCIN; BUSULFAN; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GLOBULIN; HEMOGLOBIN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; METHOTREXATE; MYCOPHENOLIC ACID; NITROGEN; TACROLIMUS; THYMOCYTE ANTIBODY; UNINDEXED DRUG; UREA; URIC ACID; VINCRISTINE;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BONE MARROW RESCUE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DONOR; DOSE RESPONSE; DRUG MEGADOSE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; RASH; REFRACTORY PERIOD; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; DISEASE-FREE SURVIVAL; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034486239     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702730     Document Type: Article

References (13)

1. Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma - Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the marrow transplantation
2. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: A report from the European lymphoma bone marrow transplantation registry
3. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
4. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma
5. Effective treatment of small-noncleaved-cell lymphoma with high-intensity brief duration chemotherapy
6. HiC-COM a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia
7. Graft-versus-leukemia reactions after bone marrow transplantation
8. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
9. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
10. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
11. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
12. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukemia and lymphoma
13. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation